STRATA Skin Sciences Inc
NASDAQ:SSKN

Watchlist Manager
STRATA Skin Sciences Inc Logo
STRATA Skin Sciences Inc
NASDAQ:SSKN
Watchlist
Price: 0.13 USD -23.08%
Market Cap: $765.7k

EV/EBIT

-1.1
Current
75%
Cheaper
vs 3-y average of -4.4

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
-1.1
=
Enterprise Value
$7.8m
/
EBIT
$-6.5m

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
-1.1
=
Enterprise Value
$7.8m
/
EBIT
$-6.5m

Valuation Scenarios

STRATA Skin Sciences Inc is trading above its industry average

If EV/EBIT returns to its Industry Average (19.2), the stock would be worth $-2.27 (1 846% downside from current price).

Statistics
Positive Scenarios
0/2
Maximum Downside
-1 880%
Maximum Upside
No Upside Scenarios
Average Downside
1 863%
Scenario EV/EBIT Value Implied Price Upside/Downside
Current Multiple -1.1 $0.13
0%
Industry Average 19.2 $-2.27
-1 846%
Country Average 19.6 $-2.31
-1 880%

Forward EV/EBIT
Today’s price vs future ebit

Not enough data available to calculate forward EV/EBIT

Peer Comparison

All Multiples
EV/EBIT
P/E
All Countries
Close

Market Distribution

Lower than 100% of companies in the United States of America
Percentile
0th
Based on 8 638 companies
0th percentile
-1.1
Low
0 — 13.6
Typical Range
13.6 — 27.8
High
27.8 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 13.6
Median 19.6
70th Percentile 27.8
Max 1 826 183.2

STRATA Skin Sciences Inc
Glance View

Market Cap
765.7k USD
Industry
Health Care

STRATA Skin Sciences, Inc. is a medical technology company in Dermatology and Plastic Surgery. The company is headquartered in Horsham, Pennsylvania and currently employs 115 full-time employees. The company went IPO on 2005-10-28. The firm is engaged in plastic surgery, developing, commercializing and marketing products for the treatment of dermatologic conditions. The firm operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. The firm's XTRAC excimer laser delivers a targeted therapeutic beam of ultraviolet B (UVB) light to treat psoriasis, vitiligo, eczema, atopic dermatitis and leukoderma. Pharos is its excimer laser device that emits concentrated ultraviolet (UV) light and is used as a tool in the treatment of dermatological skin disorders. VTRAC is a UV light lamp system utilized in the treatment of psoriasis, vitiligo and various other skin conditions.

SSKN Intrinsic Value
Not Available
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett